LRRK2 and Parkinson disease: Taken together, these observations indicate that LRRK2 might be implicated in the pathogenesis of AD and PD in multiple ways and, importantly, suggest that targeting LRRK2 kinase activity could also be beneficial to reducing the spread of these diseases.